These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 12370822
1. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H. Oncogene; 2002 Oct 10; 21(46):7001-10. PubMed ID: 12370822 [Abstract] [Full Text] [Related]
2. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R. Cell Growth Differ; 1997 Dec 10; 8(12):1267-76. PubMed ID: 9419415 [Abstract] [Full Text] [Related]
3. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L, Turkson J, Karras JG, Jove R, Haura EB. Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138 [Abstract] [Full Text] [Related]
4. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Kreis S, Munz GA, Haan S, Heinrich PC, Behrmann I. Mol Cancer Res; 2007 Dec 03; 5(12):1331-41. PubMed ID: 18171991 [Abstract] [Full Text] [Related]
5. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Karni R, Jove R, Levitzki A. Oncogene; 1999 Aug 19; 18(33):4654-62. PubMed ID: 10467412 [Abstract] [Full Text] [Related]
6. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE. Oncogene; 2002 Nov 21; 21(53):8075-88. PubMed ID: 12444544 [Abstract] [Full Text] [Related]
7. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, Van Etten RA, Baumann H. Hepatology; 1999 Sep 21; 30(3):682-97. PubMed ID: 10462375 [Abstract] [Full Text] [Related]
8. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Oncogene; 2002 Mar 27; 21(13):2000-8. PubMed ID: 11960372 [Abstract] [Full Text] [Related]
9. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Buettner R, Mora LB, Jove R. Clin Cancer Res; 2002 Apr 27; 8(4):945-54. PubMed ID: 11948098 [Abstract] [Full Text] [Related]
10. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R. Oncogene; 2002 Dec 12; 21(57):8804-16. PubMed ID: 12483533 [Abstract] [Full Text] [Related]
11. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. Oncogene; 2001 May 03; 20(20):2499-513. PubMed ID: 11420660 [Abstract] [Full Text] [Related]
12. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity. Wang YZ, Wharton W, Garcia R, Kraker A, Jove R, Pledger WJ. Oncogene; 2000 Apr 20; 19(17):2075-85. PubMed ID: 10815799 [Abstract] [Full Text] [Related]
13. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Leu CM, Wong FH, Chang C, Huang SF, Hu CP. Oncogene; 2003 Oct 30; 22(49):7809-18. PubMed ID: 14586407 [Abstract] [Full Text] [Related]
14. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F. Mol Cancer Res; 2008 Jan 30; 6(1):42-52. PubMed ID: 18234961 [Abstract] [Full Text] [Related]
15. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas. Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M, Germano G, Bono M, Capillo M, Pelicci P, Lanfrancone L. Cancer Res; 2007 Apr 01; 67(7):3064-73. PubMed ID: 17409413 [Abstract] [Full Text] [Related]
16. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Paner GP, Silberman S, Hartman G, Micetich KC, Aranha GV, Alkan S. Anticancer Res; 2003 Apr 01; 23(3B):2253-60. PubMed ID: 12894500 [Abstract] [Full Text] [Related]
17. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C, Bonavida B. Oncogene; 2004 Apr 29; 23(20):3530-40. PubMed ID: 15077178 [Abstract] [Full Text] [Related]
18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M. Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214 [Abstract] [Full Text] [Related]
19. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Zhang T, Ma J, Cao X. Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832 [Abstract] [Full Text] [Related]
20. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264 [Abstract] [Full Text] [Related] Page: [Next] [New Search]